Diametric Capital, LP Pacific Biosciences Of California, Inc. Transaction History

Diametric Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $171,488 - $290,259	20,837 New	20,837 $173,000
Q1 2023 May 11, 2023	BUY	$7.94 - $12.02 $515,544 - $780,458	64,930 Added 192.32%	98,692 $1.14 Million
Q4 2022 Mar 29, 2023	SELL	$5.67 - $11.2 $1.14 Million - $2.25 Million	-200,945 Reduced 85.62%	33,762 $276,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $922,398 - $2.01 Million	234,707 New	234,707 $1.36 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.